Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.

Abstract excerpt

Despite scientific efforts and significant progress in understanding the basic cellular event in pancreatic adenocarcinoma (PA), survival rates have not changed much during the last 20 years. Prognosis in pancreatic cancer remains unsatisfactory due to its late clinical presentation, low surgical resectability rates, and resistance to chemotherapy. Novel therapeutic strategies are needed in order to improve the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to ErbB Receptors
• Share to Adenocarcinoma